fda decision: gedatolisib by celcuity inc. (on 2026-01-01)
Denied (CRL Issued)
fda decision: gedatolisib by celcuity inc. (on 2026-01-01). Best Yes near 11¢ across 1 platform. Live cross-platform prices. Not financial advice.
Best Yes: 11¢ · Best No: 96¢ · 1 platform
- Kalshi: Yes 11¢ / No 96¢
LIVE
Denied (CRL Issued)
Volume
$0
$0 24h
Platforms
1
Cross-platform pricing
Resolution
Resolves Aug 1, 2026
~46 days left
Category
Economics
Yes
11¢
Kalshi
No
96¢
Kalshi
Opens on best-price platform
Compare & Trade
1 platform
Price History
Loading…
About This Market
If the FDA's decision on Gedatolisib by Celcuity Inc. in July 2026 is Denied (CRL Issued) before Aug 1, 2026, the market resolves to Yes.
Market Details
ResolutionResolves Aug 1, 2026
Time Left46 days
Status● Active
CategoryEconomics
Yes
11¢
Kalshi
Payout 9.1x
No
96¢
Kalshi
Payout 1.0x
Opens on best-price platform
Compare & Trade
1 platformSign in to join the discussion
Sign In